Discoloration source and control of a biotechnological drug product manufactured using a high titer production process
- 28 October 2025
- journal article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 115 (1) , 104045
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Techniques for Developing Reliable Machine Learning Classifiers Applied to Understanding and Predicting Protein:Protein Interaction Hot Spots2023
- Vitamins in cell culture media: Stability and stabilization strategiesBiotechnology and Bioengineering, 2019
- Vitamin B12 association with mAbs: Mechanism and potential mitigation strategiesBiotechnology and Bioengineering, 2017
- Advances in recombinant antibody manufacturingApplied Microbiology and Biotechnology, 2016
- Effect of cell culture medium components on color of formulated monoclonal antibody drug substanceBiotechnology Progress, 2013
- Mechanism of antibody reduction in cell culture production processesBiotechnology and Bioengineering, 2010
- Identification and prevention of antibody disulfide bond reduction during cell culture manufacturingBiotechnology and Bioengineering, 2010
- Characterization of the photodegradation of a human IgG1 monoclonal antibody formulated as a high-concentration liquid dosage formJournal of Pharmaceutical Sciences, 2009
- Engineering of a mammalian cell line for reduction of lactate formation and high monoclonal antibody productionBiotechnology and Bioengineering, 2000
- Cryo-bioorganic chemistry: molecular interactions at low temperatureCellular and Molecular Life Sciences, 1999